Design and validation of a medication assessment tool for cancer pain management

Håkonsen, Gro Dahlseng; Hudson, Steve; Loennechen, Thrina

doi:10.1007/s11096-006-9060-4

Cited by 18 publications

(32 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our results indicate that MAT‐CAP criteria possess excellent overall reliability and are comparable with previous MATs . The overall applicability was lower than previously published MATs .…”

Section: Discussionsupporting

confidence: 73%

“…In MAT methodology, we transform QIs into review criteria, also called MAT criteria. The number of criteria varies in between therapy areas …”

Section: Methodsmentioning

confidence: 99%

“…A MAT can be applied routinely in a clinical setting as a checklist for clinicians or to measure guideline adherence and to identify changes in adherence over time . In literature, seven different MATs have been described—six concerning cardiovascular diseases and one concerning cancer pain management . In addition, unpublished MATs for asthma, chronic obstructive pulmonary disease (COPD), osteoporosis and obesity exist (personal communication; Mohammad Diab, University of Strathclyde).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

MAT‐CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community‐acquired pneumonia

Høgli

Småbrekke

García

2014

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 73%

“…In MAT methodology, we transform QIs into review criteria, also called MAT criteria. The number of criteria varies in between therapy areas …”

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

MAT‐CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community‐acquired pneumonia

Høgli

Småbrekke

García

2014

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

show abstract

“…Initially, we attempted to use the medication-assessment tool for cancer pain management (MAT-CP) for assessment of adherence to medication for control of cancer pain [23]. However, several criteria could not be analyzed consistently among patients.…”

Section: Discussionmentioning

confidence: 99%

A Nationwide Survey of Knowledge of and Compliance with Cancer Pain Management Guidelines by Korean Physicians

et al. 2014

View full text Add to dashboard Cite

PurposeAlthough cancer pain is prevalent, under-treatment still remains a problem. Knowledge of and compliance with guidelines for management of cancer pain were analyzed for exploration of physician-related barriers to cancer pain management. In addition, physicians' knowledge and its correlation with cancer pain control were audited.Materials and MethodsFrom July 8 to December 2, 2010, a nationwide survey of house staff enquired about their knowledge of cancer pain control guidelines, and the medical records of patients under their care were analyzed.ResultsIn total, 180 physicians participated in the study. Their average score for knowledge was 14.6 (range, 7 to 19; maximum possible, 20). When the knowledge score was divided into low, medium, and high scores, patients receiving care from physicians with high levels of knowledge tended to have better cancer pain control (p<0.001). Of the total patients with severe pain, 19.5% were not prescribed strong opioids, and 40% were not prescribed any medication for breakthrough pain.ConclusionPhysicians' knowledge of guidelines for control of cancer pain showed an association with improvement of pain management. Overall adherence to the guidelines was lacking. Continuous interventions such as education and audits regarding cancer pain control guidelines for physician are needed.

show abstract

“…Medication assessment tools are novel evidence‐based instruments intended for evaluation of prescribing trends and adherence to international guidelines. These have already been implemented and specifically designed in the management of heart failure, coronary disease, asthma and pain management in cancer patients . The aim of this research was to design, and validate a medication assessment tool (RhMAT, rheumatoid arthritis medication assessment tool) specifically for rheumatoid arthritis patients.…”

Section: Introductionmentioning

confidence: 99%

Development and validation of RhMAT, as medication assessment tool specifically designed for rheumatoid arthritis management

Grech

Ferrito

Serracino‐Inglott

et al. 2015

J Pharm Health Serv Res

View full text Add to dashboard Cite

Objectives The implementation of individualised pharmaceutical care plans based on the identification of pharmaceutical care issues for rheumatoid arthritis patients presenting at outpatient clinic service has been proven to be effective in improving the quality of life of these patients. However, the identification and classification of pharmaceutical care issues into drug therapy problems does not give room to assessment of prescribing trends and adherence to international guidelines. The novel concept of medication assessment tools, is a concept which integrates pharmaceutical care issues within a larger context, that of evaluating the prescribing trends. The objective of this research was to design, and validate medication assessment tools specifically for rheumatoid arthritis patients. Methods A thorough literature review was carried out to identify the latest evidence‐based guidelines on rheumatoid arthritis pharmacotherapy. The rheumatoid arthritis medication assessment tool (RhMAT) was compiled and validated. Key findings The RhMAT consists of 11 general sections with a total of 54 criteria. For every criteria given, the researcher has an option of four responses ranging from criterion not applicable (N/A), criterion adherence (yes), criterion non‐adherence (no) and insufficient data to comment on the criterion. In cases where the criterion is not adhered to this can be justified adherence or unjustified and insufficient data for the researcher to be able to tick appropriately. The expert panel agreed with the final version of the RhMAT. Conclusion The innovative RhMAT was designed to act as a tool used by pharmacists to be able to detect gaps within patients' pharmacotherapy against evidence‐based guidelines thereby improving the quality of service offered to patients.

show abstract

Design and validation of a medication assessment tool for cancer pain management

Cited by 18 publications

References 28 publications

MAT‐CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community‐acquired pneumonia

MAT‐CAP: a novel medication assessment tool to explore adherence to clinical practice guidelines in community‐acquired pneumonia

A Nationwide Survey of Knowledge of and Compliance with Cancer Pain Management Guidelines by Korean Physicians

Development and validation of RhMAT, as medication assessment tool specifically designed for rheumatoid arthritis management

Contact Info

Product

Resources

About